The active ingredients of CSO exhibited different scores toward caspase-3, COX-2, CRH-BP, CRHR1, CRHR2, IL-1R1, IL-1R2, IL6R, IL6ST, and TNFRSF1A. The gene discussed is PTGS2; the disease is craniosynostosis.